BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28476017)

  • 1. Synergistic anti-tumor effect of bullfrog sialic acid-binding lectin and pemetrexed in malignant mesothelioma.
    Satoh T; Tatsuta T; Sugawara S; Hara A; Hosono M
    Oncotarget; 2017 Jun; 8(26):42466-42477. PubMed ID: 28476017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialic acid-binding lectin from bullfrog eggs inhibits human malignant mesothelioma cell growth in vitro and in vivo.
    Tatsuta T; Satoh T; Sugawara S; Hara A; Hosono M
    PLoS One; 2018; 13(1):e0190653. PubMed ID: 29298350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomic alterations in malignant pleural mesothelioma cells in response to long‑term treatment with bullfrog sialic acid‑binding lectin.
    Tatsuta T; Nakasato A; Sugawara S; Hosono M
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialic Acid-Binding Lectin from Bullfrog Eggs Exhibits an Anti-Tumor Effect Against Breast Cancer Cells Including Triple-Negative Phenotype Cells.
    Tatsuta T; Sato S; Sato T; Sugawara S; Suzuki T; Hara A; Hosono M
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30347895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Basic Research on Bullfrog Egg-derived Sialic Acid-binding Lectin for Cancer Treatment].
    Tatsuta T
    Yakugaku Zasshi; 2022; 142(10):1045-1053. PubMed ID: 36184438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of modification of the carboxyl groups of the sialic acid binding lectin from bullfrog (Rana catesbeiana) oocyte on anti-tumor activity.
    Iwama M; Ogawa Y; Sasaki N; Nitta K; Takayanagi Y; Ohgi K; Tsuji T; Irie M
    Biol Pharm Bull; 2001 Sep; 24(9):978-81. PubMed ID: 11558580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells.
    Hwang KE; Kim YS; Jung JW; Kwon SJ; Park DS; Cha BK; Oh SH; Yoon KH; Jeong ET; Kim HR
    Oncotarget; 2015 Oct; 6(30):29482-96. PubMed ID: 26334320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of antitumor effects of leczymes.
    Tatsuta T; Hosono M
    Glycoconj J; 2022 Apr; 39(2):157-165. PubMed ID: 35066741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Deoxy-glucose Enhances the Effect of Cisplatin and Pemetrexed in Reducing Malignant Pleural Mesothelioma Cell Proliferation But Not Spheroid Growth.
    Gerogianni I; Pitaraki E; Jagirdar RM; Kouliou O; Giannakou L; Giannopoulos S; Papazoglou E; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
    Anticancer Res; 2019 Jul; 39(7):3809-3814. PubMed ID: 31262908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialic acid-binding lectin (leczyme) induces apoptosis to malignant mesothelioma and exerts synergistic antitumor effects with TRAIL.
    Tatsuta T; Hosono M; Takahashi K; Omoto T; Kariya Y; Sugawara S; Hakomori S; Nitta K
    Int J Oncol; 2014 Feb; 44(2):377-84. PubMed ID: 24297392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced apoptosis by pemetrexed and simvastatin in malignant mesothelioma and lung cancer cells by reactive oxygen species-dependent mitochondrial dysfunction and Bim induction.
    Hwang KE; Kim YS; Hwang YR; Kwon SJ; Park DS; Cha BK; Kim BR; Yoon KH; Jeong ET; Kim HR
    Int J Oncol; 2014 Oct; 45(4):1769-77. PubMed ID: 25096993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction and cross-resistance of cisplatin and pemetrexed in malignant pleural mesothelioma cell lines.
    Kitazono-Saitoh M; Takiguchi Y; Kitazono S; Ashinuma H; Kitamura A; Tada Y; Kurosu K; Sakaida E; Sekine I; Tanabe N; Tagawa M; Tatsumi K
    Oncol Rep; 2012 Jul; 28(1):33-40. PubMed ID: 22562354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of replacing the aspartic acid/glutamic acid residues of bullfrog sialic acid binding lectin with asparagine/glutamine and arginine on the inhibition of cell proliferation in murine leukemia P388 cells.
    Ogawa Y; Iwama M; Ohgi K; Tsuji T; Irie M; Itagaki T; Kobayashi H; Inokuchi N
    Biol Pharm Bull; 2002 Jun; 25(6):722-7. PubMed ID: 12081136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma.
    Vandermeers F; Hubert P; Delvenne P; Mascaux C; Grigoriu B; Burny A; Scherpereel A; Willems L
    Clin Cancer Res; 2009 Apr; 15(8):2818-28. PubMed ID: 19351772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma.
    Gordon GJ; Mani M; Maulik G; Mukhopadhyay L; Yeap BY; Kindler HL; Salgia R; Sugarbaker DJ; Bueno R
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):549-58. PubMed ID: 17522864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pemetrexed induces apoptosis in malignant mesothelioma and lung cancer cells through activation of reactive oxygen species and inhibition of sirtuin 1.
    Hwang KE; Kim YS; Hwang YR; Kwon SJ; Park DS; Cha BK; Kim BR; Yoon KH; Jeong ET; Kim HR
    Oncol Rep; 2015 May; 33(5):2411-9. PubMed ID: 25738249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3.
    Ku JM; Hong SH; Kim HI; Kim MJ; Kim SK; Kim M; Choi SY; Park J; Kim HK; Kim JH; Seo HS; Shin YC; Ko SG
    Phytomedicine; 2020 Jan; 66():153109. PubMed ID: 31790894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma.
    Di Marzo D; Forte IM; Indovina P; Di Gennaro E; Rizzo V; Giorgi F; Mattioli E; Iannuzzi CA; Budillon A; Giordano A; Pentimalli F
    Cell Cycle; 2014; 13(4):652-65. PubMed ID: 24345738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-β produces synergistic combinatory anti-tumor effects with cisplatin or pemetrexed on mesothelioma cells.
    Li Q; Kawamura K; Yang S; Okamoto S; Kobayashi H; Tada Y; Sekine I; Takiguchi Y; Shingyouji M; Tatsumi K; Shimada H; Hiroshima K; Tagawa M
    PLoS One; 2013; 8(8):e72709. PubMed ID: 23977343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant pleural fluid from mesothelioma has potent biological activities.
    Cheah HM; Lansley SM; Varano Della Vergiliana JF; Tan AL; Thomas R; Leong SL; Creaney J; Lee YC
    Respirology; 2017 Jan; 22(1):192-199. PubMed ID: 27560254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.